ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Leukocyte Surface Antigen CD47 Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-13L520
Home | Market Reports | Health| Pharmacy
Global Leukocyte Surface Antigen CD47 Market Insights and Forecast to 2028
BUY CHAPTERS

Global Leukocyte Surface Antigen CD47 Market Research Report 2025

Code: QYRE-Auto-13L520
Report
September 2025
Pages:70
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Aurigene Discovery Technologies Ltd
Celgene Corp
Forty Seven Inc
Surface Oncology Inc
Trillium Therapeutics Inc

Leukocyte Surface Antigen CD47 Market

The global market for Leukocyte Surface Antigen CD47 was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Leukocyte Surface Antigen CD47 is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Leukocyte Surface Antigen CD47 is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Leukocyte Surface Antigen CD47 include Aurigene Discovery Technologies Ltd, Celgene Corp, Forty Seven Inc, Surface Oncology Inc, Trillium Therapeutics Inc, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Leukocyte Surface Antigen CD47, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Leukocyte Surface Antigen CD47.
The Leukocyte Surface Antigen CD47 market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Leukocyte Surface Antigen CD47 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Leukocyte Surface Antigen CD47 manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Leukocyte Surface Antigen CD47 Market Report

Report Metric Details
Report Name Leukocyte Surface Antigen CD47 Market
Segment by Type
  • B-6H12
  • ALX-148
  • CC-90002
  • PSTx-23
  • Others
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Aurigene Discovery Technologies Ltd, Celgene Corp, Forty Seven Inc, Surface Oncology Inc, Trillium Therapeutics Inc
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Leukocyte Surface Antigen CD47 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Leukocyte Surface Antigen CD47 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Leukocyte Surface Antigen CD47 Market report?

Ans: The main players in the Leukocyte Surface Antigen CD47 Market are Aurigene Discovery Technologies Ltd, Celgene Corp, Forty Seven Inc, Surface Oncology Inc, Trillium Therapeutics Inc

What are the Application segmentation covered in the Leukocyte Surface Antigen CD47 Market report?

Ans: The Applications covered in the Leukocyte Surface Antigen CD47 Market report are Lymphoma, Ovarian Cancer, Ischemia Reperfusion Injury, Kindney Transplant Rejection, Others

What are the Type segmentation covered in the Leukocyte Surface Antigen CD47 Market report?

Ans: The Types covered in the Leukocyte Surface Antigen CD47 Market report are B-6H12, ALX-148, CC-90002, PSTx-23, Others

Recommended Reports

Antigen Diagnostics

Cell Therapy Markets

Antibody and Serum

1 Leukocyte Surface Antigen CD47 Market Overview
1.1 Product Definition
1.2 Leukocyte Surface Antigen CD47 by Type
1.2.1 Global Leukocyte Surface Antigen CD47 Market Value Comparison by Type (2024 VS 2031)
1.2.2 B-6H12
1.2.3 ALX-148
1.2.4 CC-90002
1.2.5 PSTx-23
1.2.6 Others
1.3 Leukocyte Surface Antigen CD47 by Application
1.3.1 Global Leukocyte Surface Antigen CD47 Market Value by Application (2024 VS 2031)
1.3.2 Lymphoma
1.3.3 Ovarian Cancer
1.3.4 Ischemia Reperfusion Injury
1.3.5 Kindney Transplant Rejection
1.3.6 Others
1.4 Global Leukocyte Surface Antigen CD47 Market Size Estimates and Forecasts
1.4.1 Global Leukocyte Surface Antigen CD47 Revenue 2020-2031
1.4.2 Global Leukocyte Surface Antigen CD47 Sales 2020-2031
1.4.3 Global Leukocyte Surface Antigen CD47 Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Leukocyte Surface Antigen CD47 Market Competition by Manufacturers
2.1 Global Leukocyte Surface Antigen CD47 Sales Market Share by Manufacturers (2020-2025)
2.2 Global Leukocyte Surface Antigen CD47 Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Leukocyte Surface Antigen CD47 Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Leukocyte Surface Antigen CD47, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Leukocyte Surface Antigen CD47, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Leukocyte Surface Antigen CD47, Product Type & Application
2.7 Global Key Manufacturers of Leukocyte Surface Antigen CD47, Date of Enter into This Industry
2.8 Global Leukocyte Surface Antigen CD47 Market Competitive Situation and Trends
2.8.1 Global Leukocyte Surface Antigen CD47 Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Leukocyte Surface Antigen CD47 Players Market Share by Revenue
2.8.3 Global Leukocyte Surface Antigen CD47 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Leukocyte Surface Antigen CD47 Market Scenario by Region
3.1 Global Leukocyte Surface Antigen CD47 Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Leukocyte Surface Antigen CD47 Sales by Region: 2020-2031
3.2.1 Global Leukocyte Surface Antigen CD47 Sales by Region: 2020-2025
3.2.2 Global Leukocyte Surface Antigen CD47 Sales by Region: 2026-2031
3.3 Global Leukocyte Surface Antigen CD47 Revenue by Region: 2020-2031
3.3.1 Global Leukocyte Surface Antigen CD47 Revenue by Region: 2020-2025
3.3.2 Global Leukocyte Surface Antigen CD47 Revenue by Region: 2026-2031
3.4 North America Leukocyte Surface Antigen CD47 Market Facts & Figures by Country
3.4.1 North America Leukocyte Surface Antigen CD47 Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Leukocyte Surface Antigen CD47 Sales by Country (2020-2031)
3.4.3 North America Leukocyte Surface Antigen CD47 Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Leukocyte Surface Antigen CD47 Market Facts & Figures by Country
3.5.1 Europe Leukocyte Surface Antigen CD47 Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Leukocyte Surface Antigen CD47 Sales by Country (2020-2031)
3.5.3 Europe Leukocyte Surface Antigen CD47 Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Leukocyte Surface Antigen CD47 Market Facts & Figures by Region
3.6.1 Asia Pacific Leukocyte Surface Antigen CD47 Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Leukocyte Surface Antigen CD47 Sales by Region (2020-2031)
3.6.3 Asia Pacific Leukocyte Surface Antigen CD47 Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Leukocyte Surface Antigen CD47 Market Facts & Figures by Country
3.7.1 Latin America Leukocyte Surface Antigen CD47 Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Leukocyte Surface Antigen CD47 Sales by Country (2020-2031)
3.7.3 Latin America Leukocyte Surface Antigen CD47 Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Leukocyte Surface Antigen CD47 Market Facts & Figures by Country
3.8.1 Middle East and Africa Leukocyte Surface Antigen CD47 Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Leukocyte Surface Antigen CD47 Sales by Country (2020-2031)
3.8.3 Middle East and Africa Leukocyte Surface Antigen CD47 Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Leukocyte Surface Antigen CD47 Sales by Type (2020-2031)
4.1.1 Global Leukocyte Surface Antigen CD47 Sales by Type (2020-2025)
4.1.2 Global Leukocyte Surface Antigen CD47 Sales by Type (2026-2031)
4.1.3 Global Leukocyte Surface Antigen CD47 Sales Market Share by Type (2020-2031)
4.2 Global Leukocyte Surface Antigen CD47 Revenue by Type (2020-2031)
4.2.1 Global Leukocyte Surface Antigen CD47 Revenue by Type (2020-2025)
4.2.2 Global Leukocyte Surface Antigen CD47 Revenue by Type (2026-2031)
4.2.3 Global Leukocyte Surface Antigen CD47 Revenue Market Share by Type (2020-2031)
4.3 Global Leukocyte Surface Antigen CD47 Price by Type (2020-2031)
5 Segment by Application
5.1 Global Leukocyte Surface Antigen CD47 Sales by Application (2020-2031)
5.1.1 Global Leukocyte Surface Antigen CD47 Sales by Application (2020-2025)
5.1.2 Global Leukocyte Surface Antigen CD47 Sales by Application (2026-2031)
5.1.3 Global Leukocyte Surface Antigen CD47 Sales Market Share by Application (2020-2031)
5.2 Global Leukocyte Surface Antigen CD47 Revenue by Application (2020-2031)
5.2.1 Global Leukocyte Surface Antigen CD47 Revenue by Application (2020-2025)
5.2.2 Global Leukocyte Surface Antigen CD47 Revenue by Application (2026-2031)
5.2.3 Global Leukocyte Surface Antigen CD47 Revenue Market Share by Application (2020-2031)
5.3 Global Leukocyte Surface Antigen CD47 Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Aurigene Discovery Technologies Ltd
6.1.1 Aurigene Discovery Technologies Ltd Company Information
6.1.2 Aurigene Discovery Technologies Ltd Description and Business Overview
6.1.3 Aurigene Discovery Technologies Ltd Leukocyte Surface Antigen CD47 Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Aurigene Discovery Technologies Ltd Leukocyte Surface Antigen CD47 Product Portfolio
6.1.5 Aurigene Discovery Technologies Ltd Recent Developments/Updates
6.2 Celgene Corp
6.2.1 Celgene Corp Company Information
6.2.2 Celgene Corp Description and Business Overview
6.2.3 Celgene Corp Leukocyte Surface Antigen CD47 Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Celgene Corp Leukocyte Surface Antigen CD47 Product Portfolio
6.2.5 Celgene Corp Recent Developments/Updates
6.3 Forty Seven Inc
6.3.1 Forty Seven Inc Company Information
6.3.2 Forty Seven Inc Description and Business Overview
6.3.3 Forty Seven Inc Leukocyte Surface Antigen CD47 Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Forty Seven Inc Leukocyte Surface Antigen CD47 Product Portfolio
6.3.5 Forty Seven Inc Recent Developments/Updates
6.4 Surface Oncology Inc
6.4.1 Surface Oncology Inc Company Information
6.4.2 Surface Oncology Inc Description and Business Overview
6.4.3 Surface Oncology Inc Leukocyte Surface Antigen CD47 Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Surface Oncology Inc Leukocyte Surface Antigen CD47 Product Portfolio
6.4.5 Surface Oncology Inc Recent Developments/Updates
6.5 Trillium Therapeutics Inc
6.5.1 Trillium Therapeutics Inc Company Information
6.5.2 Trillium Therapeutics Inc Description and Business Overview
6.5.3 Trillium Therapeutics Inc Leukocyte Surface Antigen CD47 Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Trillium Therapeutics Inc Leukocyte Surface Antigen CD47 Product Portfolio
6.5.5 Trillium Therapeutics Inc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Leukocyte Surface Antigen CD47 Industry Chain Analysis
7.2 Leukocyte Surface Antigen CD47 Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Leukocyte Surface Antigen CD47 Production Mode & Process Analysis
7.4 Leukocyte Surface Antigen CD47 Sales and Marketing
7.4.1 Leukocyte Surface Antigen CD47 Sales Channels
7.4.2 Leukocyte Surface Antigen CD47 Distributors
7.5 Leukocyte Surface Antigen CD47 Customer Analysis
8 Leukocyte Surface Antigen CD47 Market Dynamics
8.1 Leukocyte Surface Antigen CD47 Industry Trends
8.2 Leukocyte Surface Antigen CD47 Market Drivers
8.3 Leukocyte Surface Antigen CD47 Market Challenges
8.4 Leukocyte Surface Antigen CD47 Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Aurigene Discovery Technologies Ltd
Celgene Corp
Forty Seven Inc
Surface Oncology Inc
Trillium Therapeutics Inc
List of Tables
 Table 1. Global Leukocyte Surface Antigen CD47 Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Leukocyte Surface Antigen CD47 Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Leukocyte Surface Antigen CD47 Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Leukocyte Surface Antigen CD47 Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Leukocyte Surface Antigen CD47 Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Leukocyte Surface Antigen CD47 Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Leukocyte Surface Antigen CD47 Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Leukocyte Surface Antigen CD47 Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Leukocyte Surface Antigen CD47, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Leukocyte Surface Antigen CD47, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Leukocyte Surface Antigen CD47, Product Type & Application
 Table 12. Global Key Manufacturers of Leukocyte Surface Antigen CD47, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Leukocyte Surface Antigen CD47 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leukocyte Surface Antigen CD47 as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Leukocyte Surface Antigen CD47 Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Leukocyte Surface Antigen CD47 Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Leukocyte Surface Antigen CD47 Sales Market Share by Region (2020-2025)
 Table 19. Global Leukocyte Surface Antigen CD47 Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Leukocyte Surface Antigen CD47 Sales Market Share by Region (2026-2031)
 Table 21. Global Leukocyte Surface Antigen CD47 Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Region (2020-2025)
 Table 23. Global Leukocyte Surface Antigen CD47 Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Region (2026-2031)
 Table 25. North America Leukocyte Surface Antigen CD47 Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Leukocyte Surface Antigen CD47 Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Leukocyte Surface Antigen CD47 Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Leukocyte Surface Antigen CD47 Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Leukocyte Surface Antigen CD47 Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Leukocyte Surface Antigen CD47 Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Leukocyte Surface Antigen CD47 Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Leukocyte Surface Antigen CD47 Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Leukocyte Surface Antigen CD47 Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Leukocyte Surface Antigen CD47 Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Leukocyte Surface Antigen CD47 Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Leukocyte Surface Antigen CD47 Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Leukocyte Surface Antigen CD47 Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Leukocyte Surface Antigen CD47 Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Leukocyte Surface Antigen CD47 Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Leukocyte Surface Antigen CD47 Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Leukocyte Surface Antigen CD47 Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Leukocyte Surface Antigen CD47 Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Leukocyte Surface Antigen CD47 Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Leukocyte Surface Antigen CD47 Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Leukocyte Surface Antigen CD47 Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Leukocyte Surface Antigen CD47 Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Leukocyte Surface Antigen CD47 Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Leukocyte Surface Antigen CD47 Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Leukocyte Surface Antigen CD47 Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Leukocyte Surface Antigen CD47 Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Leukocyte Surface Antigen CD47 Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Leukocyte Surface Antigen CD47 Sales Market Share by Type (2020-2025)
 Table 53. Global Leukocyte Surface Antigen CD47 Sales Market Share by Type (2026-2031)
 Table 54. Global Leukocyte Surface Antigen CD47 Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Leukocyte Surface Antigen CD47 Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Type (2020-2025)
 Table 57. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Type (2026-2031)
 Table 58. Global Leukocyte Surface Antigen CD47 Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Leukocyte Surface Antigen CD47 Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Leukocyte Surface Antigen CD47 Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Leukocyte Surface Antigen CD47 Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Leukocyte Surface Antigen CD47 Sales Market Share by Application (2020-2025)
 Table 63. Global Leukocyte Surface Antigen CD47 Sales Market Share by Application (2026-2031)
 Table 64. Global Leukocyte Surface Antigen CD47 Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Leukocyte Surface Antigen CD47 Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Application (2020-2025)
 Table 67. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Application (2026-2031)
 Table 68. Global Leukocyte Surface Antigen CD47 Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Leukocyte Surface Antigen CD47 Price (USD/Pcs) by Application (2026-2031)
 Table 70. Aurigene Discovery Technologies Ltd Company Information
 Table 71. Aurigene Discovery Technologies Ltd Description and Business Overview
 Table 72. Aurigene Discovery Technologies Ltd Leukocyte Surface Antigen CD47 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. Aurigene Discovery Technologies Ltd Leukocyte Surface Antigen CD47 Product
 Table 74. Aurigene Discovery Technologies Ltd Recent Developments/Updates
 Table 75. Celgene Corp Company Information
 Table 76. Celgene Corp Description and Business Overview
 Table 77. Celgene Corp Leukocyte Surface Antigen CD47 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. Celgene Corp Leukocyte Surface Antigen CD47 Product
 Table 79. Celgene Corp Recent Developments/Updates
 Table 80. Forty Seven Inc Company Information
 Table 81. Forty Seven Inc Description and Business Overview
 Table 82. Forty Seven Inc Leukocyte Surface Antigen CD47 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. Forty Seven Inc Leukocyte Surface Antigen CD47 Product
 Table 84. Forty Seven Inc Recent Developments/Updates
 Table 85. Surface Oncology Inc Company Information
 Table 86. Surface Oncology Inc Description and Business Overview
 Table 87. Surface Oncology Inc Leukocyte Surface Antigen CD47 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. Surface Oncology Inc Leukocyte Surface Antigen CD47 Product
 Table 89. Surface Oncology Inc Recent Developments/Updates
 Table 90. Trillium Therapeutics Inc Company Information
 Table 91. Trillium Therapeutics Inc Description and Business Overview
 Table 92. Trillium Therapeutics Inc Leukocyte Surface Antigen CD47 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. Trillium Therapeutics Inc Leukocyte Surface Antigen CD47 Product
 Table 94. Trillium Therapeutics Inc Recent Developments/Updates
 Table 95. Key Raw Materials Lists
 Table 96. Raw Materials Key Suppliers Lists
 Table 97. Leukocyte Surface Antigen CD47 Distributors List
 Table 98. Leukocyte Surface Antigen CD47 Customers List
 Table 99. Leukocyte Surface Antigen CD47 Market Trends
 Table 100. Leukocyte Surface Antigen CD47 Market Drivers
 Table 101. Leukocyte Surface Antigen CD47 Market Challenges
 Table 102. Leukocyte Surface Antigen CD47 Market Restraints
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Leukocyte Surface Antigen CD47
 Figure 2. Global Leukocyte Surface Antigen CD47 Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Leukocyte Surface Antigen CD47 Market Share by Type: 2024 & 2031
 Figure 4. B-6H12 Product Picture
 Figure 5. ALX-148 Product Picture
 Figure 6. CC-90002 Product Picture
 Figure 7. PSTx-23 Product Picture
 Figure 8. Others Product Picture
 Figure 9. Global Leukocyte Surface Antigen CD47 Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Leukocyte Surface Antigen CD47 Market Share by Application: 2024 & 2031
 Figure 11. Lymphoma
 Figure 12. Ovarian Cancer
 Figure 13. Ischemia Reperfusion Injury
 Figure 14. Kindney Transplant Rejection
 Figure 15. Others
 Figure 16. Global Leukocyte Surface Antigen CD47 Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Leukocyte Surface Antigen CD47 Market Size (2020-2031) & (US$ Million)
 Figure 18. Global Leukocyte Surface Antigen CD47 Sales (2020-2031) & (K Pcs)
 Figure 19. Global Leukocyte Surface Antigen CD47 Average Price (USD/Pcs) & (2020-2031)
 Figure 20. Leukocyte Surface Antigen CD47 Report Years Considered
 Figure 21. Leukocyte Surface Antigen CD47 Sales Share by Manufacturers in 2024
 Figure 22. Global Leukocyte Surface Antigen CD47 Revenue Share by Manufacturers in 2024
 Figure 23. Global 5 and 10 Largest Leukocyte Surface Antigen CD47 Players: Market Share by Revenue in Leukocyte Surface Antigen CD47 in 2024
 Figure 24. Leukocyte Surface Antigen CD47 Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 25. Global Leukocyte Surface Antigen CD47 Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 26. North America Leukocyte Surface Antigen CD47 Sales Market Share by Country (2020-2031)
 Figure 27. North America Leukocyte Surface Antigen CD47 Revenue Market Share by Country (2020-2031)
 Figure 28. U.S. Leukocyte Surface Antigen CD47 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Canada Leukocyte Surface Antigen CD47 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Europe Leukocyte Surface Antigen CD47 Sales Market Share by Country (2020-2031)
 Figure 31. Europe Leukocyte Surface Antigen CD47 Revenue Market Share by Country (2020-2031)
 Figure 32. Germany Leukocyte Surface Antigen CD47 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. France Leukocyte Surface Antigen CD47 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. U.K. Leukocyte Surface Antigen CD47 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Italy Leukocyte Surface Antigen CD47 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Russia Leukocyte Surface Antigen CD47 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Asia Pacific Leukocyte Surface Antigen CD47 Sales Market Share by Region (2020-2031)
 Figure 38. Asia Pacific Leukocyte Surface Antigen CD47 Revenue Market Share by Region (2020-2031)
 Figure 39. China Leukocyte Surface Antigen CD47 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Japan Leukocyte Surface Antigen CD47 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. South Korea Leukocyte Surface Antigen CD47 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. India Leukocyte Surface Antigen CD47 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Australia Leukocyte Surface Antigen CD47 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Taiwan Leukocyte Surface Antigen CD47 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Indonesia Leukocyte Surface Antigen CD47 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Thailand Leukocyte Surface Antigen CD47 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Malaysia Leukocyte Surface Antigen CD47 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Philippines Leukocyte Surface Antigen CD47 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Latin America Leukocyte Surface Antigen CD47 Sales Market Share by Country (2020-2031)
 Figure 50. Latin America Leukocyte Surface Antigen CD47 Revenue Market Share by Country (2020-2031)
 Figure 51. Mexico Leukocyte Surface Antigen CD47 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Brazil Leukocyte Surface Antigen CD47 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Argentina Leukocyte Surface Antigen CD47 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Middle East and Africa Leukocyte Surface Antigen CD47 Sales Market Share by Country (2020-2031)
 Figure 55. Middle East and Africa Leukocyte Surface Antigen CD47 Revenue Market Share by Country (2020-2031)
 Figure 56. Turkey Leukocyte Surface Antigen CD47 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Saudi Arabia Leukocyte Surface Antigen CD47 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. UAE Leukocyte Surface Antigen CD47 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 59. Global Sales Market Share of Leukocyte Surface Antigen CD47 by Type (2020-2031)
 Figure 60. Global Revenue Market Share of Leukocyte Surface Antigen CD47 by Type (2020-2031)
 Figure 61. Global Leukocyte Surface Antigen CD47 Price (USD/Pcs) by Type (2020-2031)
 Figure 62. Global Sales Market Share of Leukocyte Surface Antigen CD47 by Application (2020-2031)
 Figure 63. Global Revenue Market Share of Leukocyte Surface Antigen CD47 by Application (2020-2031)
 Figure 64. Global Leukocyte Surface Antigen CD47 Price (USD/Pcs) by Application (2020-2031)
 Figure 65. Leukocyte Surface Antigen CD47 Value Chain
 Figure 66. Channels of Distribution (Direct Vs Distribution)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global Leukocyte Surface Antigen CD47 Antibody Market Research Report 2024
Global CD47 IAP Market Research Report 2025
Global Leukocyte Differentiation Antigen Detection Kit Market Research Report 2024
Global T Lymphocyte Activation Antigen CD86 Market Research Report 2024
HSP47 ELISA Kit Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Bacterial Antigens Market Research Report 2024
Global Antigen Microarray Market Research Report 2025
Global Rapid Antigen Testing Market Research Report 2024
Global Antigen Rapid Test Market Research Report 2025
Global CD79a Antibody Market Research Report 2024
Cell Surface Markers Market
Global Chimeric Antigen Receptor T Cell Therapy Market Research Report 2024
Global GFAP Antibody Market Research Report 2024
Global Anti CD19 Market Research Report 2024
Global PD 1 and PD L1 Monoclonal Antibody Market Research Report 2025
Global Bacterial and Viral Antigens Market Research Report 2024
Global CD Antigen Cancer Therapy Market Research Report 2025
Global Flow Cytometry Antibody Products Market Research Report 2025
Global Human Leukocyte Antigen Testing Market Research Report 2024
Global CAPG Antibody Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions